2013
DOI: 10.14412/2074-2711-2013-2420
|View full text |Cite
|
Sign up to set email alerts
|

Locomotor therapy with extended-release crystalline glucocorticoids

Abstract: Терапия глюкокортикоидами (ГК) наряду с нестероид-ными противовоспалительными препаратами (НПВП) -ос-нова симптоматической противовоспалительной терапии за-болеваний опорно-двигательного аппарата. ГК являются са-мыми мощными противовоспалительными средствами и пре-паратами выбора при многих патологических состояниях, ко-гда необходимо быстро купировать или существенно умень-шить интенсивность боли, воспалительную активность, экс-судативные явления в пораженных суставах и улучшить функ-циональную способность су… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 1 publication
0
0
0
Order By: Relevance
“…Currently, a promising direction in the treatment of autoimmune arthritis is local therapy with prolonged nanostructured forms of glucocorticosteroids (GCSs). Due to the creation of a high local concentration, such forms contribute to more effective compensation of the inflammatory process in the joint and periarticular tissues (Badokin 2013). Previously, we developed a liposomal extended-release form of dexamethasone and showed its greater efficacy compared to the water-soluble form in animals with an autoimmune arthritis model (Kulikov et al 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, a promising direction in the treatment of autoimmune arthritis is local therapy with prolonged nanostructured forms of glucocorticosteroids (GCSs). Due to the creation of a high local concentration, such forms contribute to more effective compensation of the inflammatory process in the joint and periarticular tissues (Badokin 2013). Previously, we developed a liposomal extended-release form of dexamethasone and showed its greater efficacy compared to the water-soluble form in animals with an autoimmune arthritis model (Kulikov et al 2021).…”
Section: Introductionmentioning
confidence: 99%